Histone deacetylase inhibitors suppress expression of the apoptosis inhibitor survivin in renal cell carcinoma cells

被引：0
|
作者：
Mueller, M
Weikert, S
Mussler, A
Krause, H
Miller, K
机构：
来源：
JOURNAL OF UROLOGY | 2004年 / 171卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)38247-8
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：267 / 267
页数：1
相关论文
共 50 条
  • [41] Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
    Freese, Kim
    Seitz, Tatjana
    Dietrich, Peter
    Lee, Serene M. L.
    Thasler, Wolfgang E.
    Bosserhoff, Anja
    Hellerbrand, Claus
    CANCERS, 2019, 11 (10)
  • [42] Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
    Yan, W.
    Liu, S.
    Xu, E.
    Zhang, J.
    Zhang, Y.
    Chen, X.
    Chen, X.
    ONCOGENE, 2013, 32 (05) : 599 - 609
  • [43] Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8
    W Yan
    S Liu
    E Xu
    J Zhang
    Y Zhang
    X Chen
    X Chen
    Oncogene, 2013, 32 : 599 - 609
  • [44] Historic deacetylase inhibitors suppress TFF expression in gastric epithelial cells
    Shimada, T
    Koitabashi, A
    Hashimoto, T
    Hosaka, K
    Tabei, K
    Yoneda, M
    Hiraishi, H
    Terano, A
    GASTROENTEROLOGY, 2003, 124 (04) : A456 - A456
  • [45] Enhancement of Ad5-TRAIL cytotoxicity against renal cell carcinoma with histone deacetylase inhibitors
    VanOosten, R. L.
    Earel, J. K., Jr.
    Griffith, T. S.
    CANCER GENE THERAPY, 2006, 13 (06) : 628 - 632
  • [46] The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinoma in vitro and in vivo
    Jones, Jon
    Juengel, Eva
    Mickuckyte, Ausra
    Hudak, Lukasz
    Wedel, Steffen
    Jonas, Dietger
    Blaheta, Roman
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (8B) : 2376 - 2385
  • [47] Enhancement of Ad5-TRAIL cytotoxicity against renal cell carcinoma with histone deacetylase inhibitors
    R L VanOosten
    J K Earel
    T S Griffith
    Cancer Gene Therapy, 2006, 13 : 628 - 632
  • [48] Histone deacetylase inhibitor(TSA) increases cell-ECM interaction in colon carcinoma cells
    Oh, ES
    Kim, YH
    Lim, YM
    Park, H
    Kim, S
    Kwon, HJ
    MOLECULAR BIOLOGY OF THE CELL, 2001, 12 : 192A - 192A
  • [49] A histone deacetylase inhibitor enhances adenoviral infection of renal cancer cells
    Okegawa, Takatsugu
    Sayne, Jennifer R.
    Nutahara, Kikuo
    Pong, Rey-Chen
    Saboorian, Hossain
    Kabbani, Wareef
    Higashihara, Eiji
    Hsieh, Jer-Tsong
    JOURNAL OF UROLOGY, 2007, 177 (03): : 1148 - 1156
  • [50] A proteosome inhibitor synergizes with histone deacetylase inhibitor-induced cell death and redifferentiation of thyroid carcinoma cells
    Shimura, Hiroki
    Furuya, Fumihiko
    Aoyagi, Miho
    Ohta, Kazuyasu
    Endo, Toyoshi
    Kobayashi, Tetsuro
    ENDOCRINE JOURNAL, 2010, 57 : S463 - S463
12345